Hologic is now the sole supplier of Sentimag in North America

From screening through surgery, Hologic has shown that it’s the only company in North America that’s able to offer breast care solutions across the entire treatment pathway.  

By adding Sentimag to its existing technologies, healthcare providers will now have greater access to superior tools and technologies needed to deliver the best possible outcomes at every stage of each patient’s journey. 

Since Hologic acquired Endomag in July 2024, we’ve worked hand-in-hand to advance our shared mission: delivering a higher standard of breast cancer care for patients everywhere.  

Now, by offering our innovative technologies directly through Hologic in North America, we’re entering an exciting new chapter— one that brings more resources and expertise to every physician and patient we serve. 

As global leaders in women’s health, Hologic has led the way in driving awareness of the need for better outcomes through the Women’s Health Index. Coupled with their state-of-the-art technologies such as the Brevera® biopsy system and the 3Dimensions™ mammography system, their commitment to improving women’s lives could not be more aligned with ours. 

Now, with the addition of the Sentimag® platform to Hologic’s portfolio — including the Magseed® markers and Magtrace® lymphatic tracer — we’re setting a new standard not only in surgical guidance but across the entire breast cancer treatment pathway. 

Together, we can better support the thousands of physicians who rely on Sentimag to deliver exceptional care, while opening doors for even more hospitals to access the gold standard in all-in-one surgical guidance.  

This ensures that wherever patients are on their journey, they’ll have access to the treatment they need for the best possible outcomes. 

• Alongside Endomag, Hologic’s dedicated account representatives are here to make this transition seamless. They’ll be your main point of contact for all our products, ensuring you continue to receive the world-class support you’ve come to expect. 
• Note that Mammotome (formerly Devicor Medical Products, Inc) will no longer distribute Endomag products. 

 → Speak to a local representative 

Please note that this update refers to Hologic now providing Endomag's technologies in the U.S. and Canada. All other countries will continue to operate under their existing distributor or Endomag. More guidance on other markets will be provided at a later date. Click here to see our full list of suppliers.  

As we embark on this new chapter with Hologic, we remain dedicated to our mission: advancing breast cancer care for patients everywhere, and are excited to continue supporting you every step of the way.